Mind Medicine announces election of all six company nominees at annual meeting

Mind Medicine announced that, based upon a preliminary vote assessment, shareholders have elected all six of the company’s nominees – CEO Robert Barrow, Dr. Suzanne Bruhn, Dr. Roger Crystal, David Gryska, Andreas Krebs and Carol A. Vallone – to the Board of Directors at the Annual Meeting of Shareholders held Wednesday. Robert Barrow, CEO and Director of MindMed, stated: “We would like to sincerely thank our shareholders for their support and engagement throughout this process. We would also like to thank both independent proxy advisory firms – Institutional Shareholder Services and Glass, Lewis & Co. – for their recommendations, which validated our strategy and the quality of our directors. The entire Board is fully committed to the Company’s success as we navigate this pivotal period, with two key clinical readouts expected later this year. We are glad to put this proxy contest behind us and fully focus on bringing our transformative therapies to market in order to help patients in need and deliver value for all shareholders.”